The lack of detail with the Pfizer deal available to the pleb...

The lack of detail with the Pfizer deal available to the pleb traders/investors is a major problem. No schedule, value for milestones or indication from PSD that they are confident of achieving each milestone.

However, I take the accumulation of 12 million, in market shares by Top 10 shareholders over the past 5 weeks as a positive sign. I will hold and wait in hope of a clear and positive announcement.